CARBOGEN AMCIS leverages its world-class chemistry skills to provide seamless drug substance, drug products development and commercialization services for leading pharmaceutical and biopharmaceutical companies. We help customers create a better world by becoming the partner of choice thanks to our innovative solutions. We offer an array of integrated and customized services operating in a fully cGMP-compliant infrastructure, including dedicated Highly Potent API facilities and a clean room for Antibody Drug Conjugates. Beyond our services, we also provide high-quality Cholesterol and Vitamin D analogs. CARBOGEN AMCIS is owned by Dishman Carbogen Amcis Limited, (India).
Learn more about us: www.carbogen-amcis.com
|
|
|
|
|
501-1,000 employees
View all CARBOGEN AMCIS employees
|
|
|
Pharmaceutical Manufacturing
|
|
|
Hauptstrasse 171, Bubendorf, CH
|
|
|
Process Research & Development, Api Custom Manufacturing, Chromatography Services, Drug Products & Drug Substances, High Potency Services, Antibody Drug Conjugates And Bioconjugation, Vitamin D Analogs & D2, Cholesterol & Lanolin Derivatives
|
Pascal Villemagne is the CEO of CARBOGEN AMCIS. To contact Pascal Villemagne email at [email protected] or [email protected].
The decision makers in CARBOGEN AMCIS are Alexander Straetz, Angie Stevens, Carlo Mbanefo, etc. Click to Find CARBOGEN AMCIS decision makers emails.
CARBOGEN AMCIS provides a comprehensive range of services for drug development, including Process Research & Development, API Custom Manufacturing, and Drug Products & Drug Substances development. Our expertise extends to high potency services, chromatography services, and specialized offerings like Antibody Drug Conjugates and Bioconjugation. We work closely with pharmaceutical and biopharmaceutical companies to ensure seamless integration of our services into their development processes.
Quality and safety are paramount at CARBOGEN AMCIS. We adhere to stringent regulatory standards and best practices in the pharmaceutical industry. Our facilities are equipped with state-of-the-art technology, and we implement rigorous quality control measures throughout the manufacturing process. Additionally, our experienced team conducts thorough testing and validation to ensure that all drug products meet the highest quality standards before they reach our clients.
Yes, CARBOGEN AMCIS specializes in high potency services. We have the necessary infrastructure, technology, and expertise to safely handle and manufacture high potency active pharmaceutical ingredients (APIs). Our facilities are designed to manage the unique challenges associated with high potency compounds, ensuring that we maintain a safe working environment while delivering high-quality products to our clients.
CARBOGEN AMCIS primarily serves the pharmaceutical and biopharmaceutical industries. We collaborate with leading companies in these sectors to provide tailored solutions for drug development and manufacturing. Our expertise in areas such as Antibody Drug Conjugates, Vitamin D Analogs, and cholesterol derivatives allows us to support a diverse range of therapeutic applications and client needs.
Engaging CARBOGEN AMCIS for a new project typically begins with an initial consultation to discuss your specific needs and objectives. Our team will assess your requirements and propose a customized plan that outlines the scope of work, timelines, and costs. Once both parties agree on the project details, we will initiate the development process, maintaining open communication throughout to ensure alignment and address any concerns that may arise.
Yes, CARBOGEN AMCIS provides support for regulatory submissions as part of our comprehensive service offerings. Our experienced team is well-versed in the regulatory landscape and can assist clients in preparing the necessary documentation for submissions to regulatory authorities. We work closely with our clients to ensure that all required information is accurately compiled and submitted in a timely manner, facilitating a smoother approval process.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.